Pulmonology Devices Market Driven by Increased Use of Advanced Inert Materials to Minimize Adverse Patient Reactions: FMI

The wide scope of devices in pulmonology healthcare, increased number of surgical procedures performed, and faster regulatory approvals are key factors that are expected to generate major growth opportunities in the industry for the coming decade. The pulmonology devices market is estimated to rise at an impressive CAGR of over 10% through the end of the forecast period in 2031. Growing patient awareness about COPD and asthma, and developments in associated government healthcare initiatives will support long term growth in the industry.

“Frequent technological advances, superior portability, and ease of handling for modern pulmonology devices are boosting adoption in home and alternate care settings as well. Furthermore, non-profit and government initiatives, and awareness programs, and an influx of funding for research studies have positively influenced developments within the industry,” says the FMI study.

Request a report sample to gain comprehensive market insights at

https://www.futuremarketinsights.com/reports/sample/rep-gb-13036

Pulmonology Devices Market – Primary Takeaways

  • Disposable, miniaturized bronchoscopes will witness increased uptake owing to lower health risks and ease of handling.
  • Chronic obstructive pulmonary disease treatment applications hold major market share, driven by its high mortality rate.
  • Awareness programs and government incentives have set up Brazil as a high potential market.
  • The U.S. holds major market share on the back of easier access to new healthcare technologies and major investments into medical infrastructure.

Pulmonology Devices Market – Growth Factors

  • Poor atmospheric conditions and widespread prevalence of respiratory ailments is generating demand.
  • Innovations in terms of home care therapeutic devices is creating lucrative growth opportunities.
  • Advances in minimally invasive surgical procedures are contributing to growth within the industry.

Pulmonology Devices Market – Major Constraints

  • Unfavorable reimbursement settings in many countries is a key factor holding back adoption rates.
  • Risk of side effects on neonatal patients is a key challenge restraining market growth.

Contact Sales for Further Assistance in Purchasing this Report@ https://www.futuremarketinsights.com/checkout/13036

Expected Impact on Market by Coronavirus Outbreak

The pulmonology devices market has been moderately affected by the ongoing covid-19 pandemic. While the market has been driven by a high volume of bronchoscopy procedures. Restrictions and postponed elective medical procedures has slowed down adoption rates. In addition, restrictions on trade have disrupted supply chains for essential raw materials and components, limiting short term growth prospects.

On the other hand, the use of specialized pulmonology devices to manage cases of respiratory failures in covid-19 patients frequent innovation in respiratory care technologies, and positive demographic trends, has helped to partially mitigate losses, and will create key lucrative opportunities for revenue generation in the near future.

Competition Landscape

Leading manufacturers operating in the pulmonology devices market include but are not limited to Merit Medical Systems, Boston Scientific Corporation, Micro-Tech (Nanjing) Co. Ltd., CONMED Corporation, Hunan Vathin, Olympus Corporation, United Medical Surgical Services Ltd., Cook Medical Incorporated, Verathon Inc., Medi-Globe GmbH, and Ambu A/S.

Major players in the pulmonology devices market are invested in strategies towards portfolio expansion. This includes efforts of product development and launch in addition to strategic mergers and acquisitions for long-term revenue generation options.

The Translational and Clinical Research Institute at Newcastle University, U.K., developed the novel Exovent negative-pressure ventilator aimed towards patients with respiratory failure, with lower levels of intrusion as compared to CPAP and positive pressure ventilation. GOQii announced approval for three wearable pulmonology devices by the Central Drugs Standard Control Organization in December 2020. Further, Olympus announced the acquisition of Veran Medical Technologies for a valuation of US$ 340 million to widen its portfolio of interventional pulmonology solutions.

Download Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-13036

More on the Report

FMI provides detailed actionable insights on the pulmonology devices market. The market is segmented in terms of product (pulmonary biopsy devices, endobronchial ultrasound needles, airway stents, airway extraction baskets, and single-use bronchoscopes), indication (lung cancer, COPD, foreign body extraction, tracheal and bronchial stenosis, and others), and end user (hospitals, pulmonology clinics, and ambulatory surgical centers), across seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Medication Management System Market: Find insights on the medication management system market with analysis of statistics, segments, players, influencers, and business strategies adopted over a 10-year forecast period.

Medical Bionic Implants and Exoskeletons Market: FMI’s report on the medical bionic implants and exoskeleton market provides insights on the market for 2017-2027. The study provides insights on restraining forces, revenue sources, market leaders, and market strategies.

Cancer Tissue Diagnostics Market: An analysis on the cancer tissue diagnostics market with information on opportunities, growth levers, regional markets, restraints, regulatory policies, and strengths of market players.

Subcutaneous Drug Delivery Market Share by 2028: Upcoming Trends and Analysis

The analysts at Future Market Insights (FMI) followed a multidisciplinary approach during the pandemic to study the growth and development of the Subcutaneous Drug Delivery Market. The report features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period 2018 to 2028.

The team of researchers at Future Business Insights are focusing on research and market study to produce different subcutaneous drug delivery market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the subcutaneous drug delivery market.

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-7676

Subcutaneous Drug Delivery Market: Key Players

Some of the global key participants operating in subcutaneous drug delivery market are: Insulet Corporation, Becton Dickinson Company, Consort Medical, West pharmaceuticals services Inc., Ypsomed AG, Elcam Medical, Sc Pharmaceuticals Inc., Steady Med Ltd, Amgen Inc., Sensile medical AG and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Subcutaneous Drug Delivery Market: Segmentation

Global Subcutaneous Drug Delivery market can be segmented on the basis of Product type, Usability, Technology and Distribution channel.

Based on the Product type Subcutaneous Drug Delivery market is segmented as

  • Fillable Injectable
  • Prefilled Injectable

Based on the usability type Subcutaneous Drug Delivery market is segmented as:

  • Disposable subcutaneous drug delivery injectable
  • Reusable subcutaneous drug delivery injectable

Based on the Technology type Subcutaneous Drug Delivery market is segmented as:

  • Jet
  • Spring
  • Gas

Based on the Distribution Channel Subcutaneous Drug Delivery market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug store
  • Online Pharmacies

For Information On The Research Approach Used In The Report, Request TOC@ https://www.futuremarketinsights.com/toc/rep-gb-7676

Queries Solved            

What is the size of the overall Subcutaneous Drug Delivery Market in the Healthcare Market and its segments?

What are the key segments and sub-segments in the market?

What are the key drivers, restraints, opportunities, and challenges of the Subcutaneous Drug Delivery Market in the Healthcare Market, and how they are expected to impact the market?

What are the attractive investment opportunities within the Subcutaneous Drug Delivery Market in the Healthcare Market?

What is the Subcutaneous Drug Delivery Market in the Healthcare Market size at the regional and country-level?

What are the key market players focusing on?

What are the strategies for growth adopted by the key players in Subcutaneous Drug Delivery Market in the Healthcare Market?

What are the recent trends in Subcutaneous Drug Delivery Market in the Healthcare Market? (M&A, partnerships, new product developments, expansions)?

What are the challenges to the Subcutaneous Drug Delivery Market in the growth of the Healthcare Market?

What are the key market trends impacting the growth of the Subcutaneous Drug Delivery Market in the Healthcare Market?

Market Background                                   

Reasons to Buy the report

  • The report includes authentic analysis of the market and the present developing trends in the market affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.
  • We provide accurate insights on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.

Our analysts provide detailed market segmentation along with useful insights and extensive reports that other companies fail to include. The report comprises the market trends, key players and shift in the demand throughout the forecasted period.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-7676

Herbal Medicinal Products Market to Manage US$ 360.35 Bn by 2031 – Future Market Insights

The herbal medicinal products market revenue totaled US$ 171.62 Bn in 2021, according to Future Market Insights (FMI) study. The overall sales of herbal medicinal products is expected to reach US$ 360.35 Bn by 2031, growing at a CAGR of 7.7 % for 2021 – 2031.

With consumer awareness regarding herbal medicines on the rise, coupled with increasing investments in the promotion of traditional medicine, sales are expected to improve at an accelerated pace. The demand for ayurvedic medicine also will grow, accounting for nearly 57% of herbal medicines sales in 2021.

Global Market Research Report Overview on Herbal Medicinal Products @ https://www.futuremarketinsights.com/press-release/herbal-medicinal-products-market

The global herbal medicinal products market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by shifting trend from conventional medicines to traditional medicines, favorable government regulations, and growing production capacity of manufacturers across the globe. According to the newly published report, “Herbal Medicinal Products Market: Global Industry Analysis.

Government initiatives undertaken around the world, especially in the West to encourage the use of herbal medicine has resulted in the development of mass distribution networks, increasing prescription of homeopathic medications, and demand for Ayurveda treatments.

According to a recent study by Future Market Insights (FMI), these factors have proven crucial at enabling growth in the herbal medicinal market. Sales of herbal medicines are expected to top US$ 171.62 Bn in 2021, at a CAGR of 7.7% during the forecast period (2021-2031).

Soaring concerns pertaining to adverse effects of allopathic medicines has been causing gradual shift of preference in favor of traditional herbal medicines. These medicines are often used for treatment of ailments including neurological diseases, cough, cold & flu, sexual problems, feminine problems, and metabolic diseases. Herbal remedies are used to maintain health and systemic balance, of body functions without sedation and side effects.

View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/herbal-medicinal-products-market/toc

In 2015, La Political de Attention Integral a la Saluda Indigene de FUNASA of Brazil promoted traditional systems of health of indigenous communities. Similarly, the government has recognized homeopathic medicines as a medical specialty and included it in the National Health System. Brazil is currently home to around 12,000 homeopathic physicians and 300 homeopathic pharmacists.

As per the World Health Organization (WHO), around 60% of the world’s population is reliant on herbal medicines for primary health care needs. In developing countries, this number accounts for up to 80%. Around 75% of such sales are made through direct user-pharmacy contacts. The growing trend of online pharmacies and mail-on-order purchases drives the demand for self-medication.

The global geriatric population is rapidly expanding with higher life expectancy rates. According to the World Bank, in 1990, the average mortality among geriatric world population was around 6 %, which increased to 9.5% in 2020. The prevalence of chronic diseases associated with an aging population portrays the need for effective medications.

Key Takeaways from Herbal Medicinal Products Market Study

  • Demand for Chinese medicines is expected to grow at 8.2% CAGR through 2031, owing to investments into promotion of traditional Chinese medicine.
  • Retail pharmacies are projected to capture over 23% of the global market by 2031. This is attributed to availability of consumer health products.
  • Europe is the largest revenue-generating region for herbal medicinal products, with Germany accounting for nearly 18% of the regional market in 2031.
  • China holds the leading position in East Asia, and is expected to account for over 49% of the market in 2031.
  • South Asia is the third most lucrative market with India accounting for over 74% of the share in 2031.

A Sample of this report is available upon request@ https://www.futuremarketinsights.com/reports/sample/rep-gb-2722

“Import-export opportunities for local players and government support for new herbal start-ups will continue creating growth opportunities for manufacturers through the assessment period ending in 2031,” says the FMI Analyst

Who is Winning?

Some of the leading manufacturers of herbal medicinal products are focusing on product launch strategies for global expansion objectives, thereby, enhancing their market presence.

  • In 2021, Arkopharma filed a patent for Quercetin and Kaempferol. These products have a genotoxic potential of plant-based preparations containing free flavones.
  • In Aug 2020, Young Living Essential Oils launched the Hand-blown Artisan Glass Diffuser, Cassia Oil-new skincare line, as additions to the Savvy Minerals makeup line. The product includes diffusers, new essential oil blends and essential oil-infused wearable rings.

Buy Full Herbal Medicinal Products Market Report@ https://www.futuremarketinsights.com/checkout/2722

The key market players covered by FMI include Blackmores Limited, Sanofi-Aventis Healthcare PTY Ltd., Arkopharma SA, Nutraceutical Corporation, STADA Arzneimittel AG, Himalaya Global Holdings Ltd, Integria Healthcare, Boiron Group, Young Living Essential Oils, and Mountain Rose Herbs.

Geospatial Solution Market Demand, Scope and Future Estimation until 2029

Faster networking is catering to the ever-growing demand for efficient geospatial information distribution and transmission. This, in turn, enables consumers and governments to more effectively use and share spatio-temporal data for real-time applications, thereby propelling geospatial solution market growth.

As indicated by a new research intelligence study of Future Market Insights (FMI), the global geospatial solution market will witness stupendous growth at a CAGR of nearly 15% during the forecast period of 2019 to 2029. This strong growth outlook of the global geospatial solution market has been attributed to the advancements in computing capacity for geospatial solution-based research and applications.

Request a report sample to gain comprehensive market insights @  https://www.futuremarketinsights.com/reports/sample/rep-gb-10696

Key Takeaways – Geospatial Solution Market Study

  • Developers are offering geomedicine solutions, which is not an emerging field, yet holds a lot of potential to boost the growth of geospatial solution market during the following years.
  • Blockchain technology is estimated to witness massive adoption in the foreseeable future. This technology can be geospatially enriched when combined with geospatial solution-based technologies such as Geographic Information System (GIS).
  • Drones are estimated to witness a considerable adoption rate during the forecast period. New standards and legislations introduced by national governments are likely to motivate drone manufacturers and end users to operate more freely, thus driving the growth of the geospatial solution market.
  • Global Positioning System (GPS) is estimated to retain a substantial revenue share in geospatial solution market.
  • Remote sensing technology will register a significant CAGR over the projection period.

High performance cloud computing services, such as cloud GIS and computing networks including CyberGIS are providing national governments with tools with which they can easily access and contribute to the growing repositories of geospatial solutions, tools, services and data.

geospatial solution market share by region 2018 a

Geospatial Information Becoming Critical Asset for Businesses

Conventionally, geospatial technology was confined to use in aeronautical and maritime organizations, intelligence agencies, and the military sector. However, the demand for geospatial solutions is rising from almost every end-use industry. Geospatial solutions have become an essential element in how organizations operate their business. At present, organizational decision making is highly dependent on data processing technologies. Thus, organizations are prioritizing geospatial data analysis as they recognize collected geospatial information as a mission critical resource to manage.

A constant search for new information tools, sources, experts, and solutions drives end-users to persistently find new and innovative ways to utilize data and discover patterns in the accumulated information using geospatial solutions. One of the most noteworthy growth areas in the broad data processing arena is data visualization. Existing end users have found geospatial solutions to be the key to efficient data visualization, irrespective of whether the accumulated information is two or three dimensional. Therefore, the geospatial solutions market is estimated to be highly attractive during the forecast period.

For more insights, You can request for TOC at @ https://www.futuremarketinsights.com/reports/geospatial-solution-market/table-of-content

U.S. Compounding Pharmacies Market to reach a valuation of US$ 6.27 Billion by the end of 2028 – Comprehensive Research Report by FMI

U.S. Compounding Pharmacies Market is projected to exceed US$ 4.64 Bn In 2022 and is expected to grow at over 5.1% CAGR between 2022 and 2028. Increasing focus on introducing innovative formulations to combat several diseases is driving the growth in the market.

According to a recent research by Future Market Insights (FMI), the global compounding pharmacies market is estimated to have accounted around US$ 4.64 Bn in terms of value during 2022. The report on the U.S. Compounding Pharmacies Market also projects that the market will grow at a CAGR of approximately 5.1% during the period 2022-2028.

Attribute Details
U.S. Compounding Pharmacies Market Estimated Size in 2022 US$ 4.64 Bn
U.S. Compounding Pharmacies Market Projected Size in 2028 US$ 6.27 Bn
U.S. Compounding Pharmacies Market Historical CAGR (2013-2021) 5.8%
U.S. Compounding Pharmacies Market Value-based CAGR (2022-2028) 5.1%

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-us-978

The U.S. compounding pharmacies market revenue is expected to increase at a robust growth rate over the next few years despite the reporting of several adverse events and drug mismanagement-related deaths. The U.S. compounding pharmacies market is expected to gain popularity in several regions of the U.S. due to upcoming products and therapeutic areas that are yet to be tapped by branded manufacturers.

Focus on factors, such as the availability of drugs in innovative medium/forms and the administration of varying dosages for various indications, is expected to drive the adoption of newer dosage forms of compounded medications.

Market Remains Influenced by Availability of Compounded Pain Management Drugs

The growing popularity of pain management therapies is fuelling the growth of U.S. compounding pharmacies market. Compounded pain management drugs are not FDA-approved, however, they come under the State Pharmacies Board supervision in the U.S.

For example, medical guidelines such as the Chronic Pain Guidelines stated by the Medical Treatment Utilization Schedule (MTUS) do not support the use of compounds such as Gabapentin and Baclofen for pain management. However, compounding pharmacies use these compounds as well as several others in varying strengths to attract customers and increase their revenue.

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-us-978

Scope of the Report

Attribute Details
Forecast Period 2022-2028
Historical Data Available for 2013-2021
Market Analysis US$ Bn for Value
Key Regions Covered North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA
Key Countries Covered United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market Segments Covered Product, Pharmacy Type, Application, and Sterility
Key Companies Profiled • Avella Specialty Pharmacy
• Central Admixture Pharmacy Services Inc.
• Hoye’s Pharmacy
• Vertisis Custom Pharmacy
• Smith Caldwell Drug Store
• Sixth Avenue Medical Pharmacy
• Cantrell Drug Company
• Clinigen Group, Dougherty’s Pharmacy
• Fagron N.V.

Moreover, an increase in the shortage of prescription medicine is expected to upsurge the demand for compounding pharmacies. According to the U.S. FDA, only 154 drugs were in short supply or not available in 2007, as compared to 456 in 2012.

Currently, the number of drugs in short supply is around 300. Medicinal drought is prominent in the U.S. as compared to other countries, which is also fuelling the revenue growth of the U.S. compounding pharmacies market.

On the other hand, increasing regulatory pressures are expected to hamper the growth of the U.S. compounding pharmacies market. Compounding pharmacies are engaged in trans-boundary drug compounding, and the manufacturing of bulk drugs & ingredients need to be registered with the FDA, undergo mandatory inspections, and abide by GMP guidelines.

For instance, the FDA has stated that around 70% of registered firms have been inspected, of which 28 firms have been issued FDA Form 483s (non-adherence to cGMP regulations and unsafe compounding practices), and five warning letters, which implies a very high rate of action.

Compounding pharmacies registering with the FDA could serve to increase credibility. However, inspections and compliance with good manufacturing practices is compulsory. Regulatory pressures on compounding pharmacies are expected to force the smaller ones to close their business primarily due to unsafe compounding practices, which are likely to directly impact patient safety.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-us-978

Hormone Replacement Therapeutic Area to Hold over 38% Revenue Share in Market

By product type, oral medication is expected to dominate the U.S. compounding pharmacies market in terms of revenue, which is then followed by topical medication. The injectable segment by product type of the U.S. compounding pharmacies market is projected to grow at a significant rate as compared to other segments.

The hormone replacement therapy segment is the leading segment in terms of revenue among all the therapeutic area segments of the U.S. compounding pharmacies market, and is estimated to gain a 38.4% revenue share in 2022.

Among the pharmacy type segments, the 503A pharmacy segment is expected to gain a major revenue share as compared to the 503B pharmacy segment over the forecast period. By application, the adults segment is estimated to dominate the U.S. compounding pharmacies market, followed by the paediatrics segment. The veterinary segment is expected to grow at a faster pace as compared to the other application segments of the U.S. compounding pharmacies market.

Buy Now@ https://www.futuremarketinsights.com/checkout/978

The U.S. compounding pharmacies market report tracks some of the key companies operating in the market, which include Avella Specialty Pharmacy, Central Admixture Pharmacy Services, Inc., Fagron N.V., Wedgewood Pharma, PharMEDium Services LLC, Doughertys Pharmacy, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Village Compounding Pharmacy, Triangle Compounding Pharmacy, Olympia Pharmacy, Hoye’s Pharmacy, Vertisis Custom Pharmacy, Smith Caldwell Drug Store, AIS HealthCare, Soleo Health, Millers Pharmacy, Centene Corporation, Infinity Care Solutions, Triumph Pharmacy, and Sixth Avenue Medical Pharmacy.

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain 

Pharma and Healthcare Social Media Market – Pharma and healthcare social media marketing is an area that is extremely relevant to the modern, digital age, where stakeholders in the pharmaceuticals and healthcare industries are reaching out to their potential customers through digital, social media platforms.

Pharmacy And Drug Store Franchises Market – A critical driver for the Pharmacy & Drug Store Franchises market is the widespread adoption of generic drugs. These drugs are identical to branded drugs in dosage, safety, strength, method of administration, characteristics & purpose of use.

Pharmaceuticals Excipients Market – Excipients can be classified into 7 categories on the basis of the kind of function they perform: diluents, binders, disintegrants, glidants, lubricants, tablet coating & films and coloring agents.

Infusion Pharmacy Management Market – Infusion therapy is type of medication through a needle or catheter. Infusion therapy is prescribed to patient only when patient condition is severe or oral medication are less effective.

Anti-Neoplastic Pharmaceutical Agents Market – Anti-neoplastic pharmaceutical agents are the drugs which prevent or inhibit the maturation and proliferation of neoplasms and thus helps in the management of cancer. These agents are also known as cytotoxic agents.

Topical Antibiotic Pharmaceuticals Market – Topical antibiotics are applied to a certain area of the skin to kill infections. Application of topical antibiotics has a number of advantages upon comparison of systemic delivery in the treatment of skin infections.

Pharmaceutical Solid Dosage Contract Manufacturing Market – The global Pharmaceutical contract manufacturing market currently is one of the rapidly growing market, and it is expected to show excellent opportunities in forecasted period.

Pharmerging Contract Manufacturing Market – Pharmerging markets indicate the most promising emerging markets in the pharmaceutical domain. Most of these markets are currently exhibiting growth rates moderate to high indicating sustainable demand prospects.

Pharmacy And Reagent Storage Refrigerators Market – Pharmacy and reagent storage refrigerators provide the reliability and security essential for the protection of sensitive lab samples. They are ideal for the demanding requirements of daily lab applications.

Biopharmaceutical Oral Drug Delivery Market – Biopharmaceuticals are the drugs produced by using biotechnology. Biopharmaceutical products are normally protein (antibodies), nucleic acids (DNA, RNA or oligonucleotides). They are used for therapeutic and in-vivo diagnostic purpose.

Oil & Gas Pipeline Coatings Market Latest Advancements and Business Opportunities 2029

Witnessing robust expansion over 2022 – 2029, the global market for oil & gas pipeline coatings will reach the revenues worth US$ 7 Bn towards 2029 end. Growing offshore exploration and production activities, stabilizing crude oil prices, rise in cross-country pipeline projects and rehabilitation of existing pipelines are some of the key factors that would majorly account for increasing demand for oil & gas pipeline coatings in the market.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-10694

Oil & gas Pipeline Coatings Market​ Key Takeaways

  • Fusion bonded epoxy (FBE) coatings, attributing to their low coefficient of friction and low permeability, create a tight barrier that prevents permeation of cold and hot liquids. This property would continue to position them as a preferred choice for oil & gas pipeline coatings.
  • The Asia Pacific region, which has more than 10,000 miles of pipeline under construction and further over 9,750 miles of planned pipeline projects, is likely to reflect robust growth opportunities facing players operating in the oil & gas pipeline coatings market.
  • With crude oil prices recovering, investments in the oil & gas industry are projected to rise by 6% between 2017 and 2025. These will fuel exploration & production activities around the world, propelling oil & gas pipeline coatings demand.
  • In the upstream segment, although onshore sector constitutes most of the market share, offshore sector, driven by increasing investments, is estimated to witness robust growth in the oil & gas pipeline coatings market.
  • Stringent regulations pertaining to volatile organic compound (VOC) emissions are anticipated to impede the growth of solvent-based oil & gas pipeline coatings, which are prone to VOC emissions during the drying process.

Pipe laying in deep waters or high operating temperatures, and increasing corrosive properties of flow materials have been driving advancements in pipeline coatings. These advances such as thermal insulation will bring forth a range of new technological frontiers in the pipeline coatings space in the near future.

Market Landscape Moving towards Consolidation

The oil & gas pipeline coatings market is technology driven and remains dominated by a handful of players that possess extensive R&D capabilities. Leading players operating in the global oil & gas pipeline coatings market, Akzo Nobel N.V., PPG INDUSTRIES, Sherwin-Williams Company, Axalta Coating Systems, RPM International Inc., and BASF SE, are focusing on acquisitions of smaller and technology-driven paint & coating manufacturers to build on their product expertise and enhance market positioning.

What Does Future Hold?

Crude oil prices are extremely volatile in nature, affected by growing U.S. oil & gas production, OPEC production cuts, and oversupply of crude oil. Considering the number of pipeline projects in the construction phase and older, existing pipelines in need of reconditioning, the oil & gas pipeline coatings market is projected to witness robust growth during the forecast period.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-10694

Interested in Detailed Actionable Insights?

Future Market Insights has published a market research report on the oil & gas pipeline coatings market that contains global industry analysis for 2014–2018 and opportunity assessment for 2019–2029. The report provides insightful analysis of the oil & gas pipeline coatings market through four different segments, namely coating type, formulation base, application, and region. The oil & gas pipeline coatings market report also provides demand trends of different coating types across three industry verticals, a comprehensive list of service providers in the market, various pipeline coating projects around the world along with a detailed overview of the parent market.

Oral Solid Dosage Pharmaceutical Formulation Market to 2027 | Growth Factors, Industry Insights : FMI

Future Market Insights forecasts the global oral solid dosage pharmaceutical formulation market to grow from US$ 493.2 Bn in 2017 to US$ 926.3 Bn by 2027 end. This represents a value CAGR of 6.5% over the forecast period 2017– 2027. Several important factors drive this growth. We present these factors in detail in our report. A snapshot is captured below for our readers’ benefit.Instead of increasing pipeline productivity for biologics and patent cliff challenges, oral solid dosage forms hold substantial opportunity in extending product lifecycle and leveraging growth potential. Manufacturers are employing various life cycle management patent strategies which include obtaining patents on isomers, metabolites, prodrugs, and new drug formulations such as extended, controlled, or rapid release formulations.Future Market Insights (FMI), in its report, projects the global oral solid dosage pharmaceutical formulation market to register 6.5% CAGR during the forecast period 2017 to 2027. In terms of revenue, the market will reach nearly US$ 500,000 Mn in 2017; by 2027 is further estimated to surpass US$ 900,000 Mn.

North America to Remain Largest Market for Oral Solid Dosage Pharmaceutical Formulation

North America will remain the largest market for oral solid dosage pharmaceutical formulation, followed by Asia Pacific Excluding Japan (APEJ) and Western Europe. Revenue from the market in North America is expected to surpass US$ 300,000 Mn by 2027-end. In addition, APEJ is projected to reach revenue worth US$ 294,750.4 Mn in the market by 2027. Latin America is expected to be the fastest growth region in the market, expanding at 9.2% CAGR through 2027. In contrast, Japan will witness a sluggish growth in the market.

By dosage form, tablets will continue to remain preferred in the market, with sales estimated to surpass US$ 500,000 Mn by 2027-end. Sales of tablets are anticipated to exhibit the highest CAGR in the market, followed by capsules. Capsules are expected to be the second most lucrative dosage form in the market, expanding at 6.1% CAGR through 2027.

Request The Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2782

Immediate Release to Remain Dominant in the Market during 2017-2027

Based on release mechanism, immediate release will remain dominant in the market, expanding at 6.4% CAGR through 2027. Immediate release is expected to generate revenue over US$ 400,000 Mn by 2027-end. Controlled release under extended release segment, is expected to register 7.4% CAGR through 2027.

Retail pharmacy is expected to be the largest end-user of oral solid dosage pharmaceutical formulation market by 2027-end. Retail pharmacy is expected to exhibit highest CAGR in the market through 2027. In contrast, Hospital pharmacy is expected to exhibit lowest CAGR, even though it stands as second largest end-user in the market during the forecast period.

Increasing Presence of MNCs to Drive Market Growth in Latin America

Latin America is emerging as a manufacturing hub for oral solid dosage forms on the back of availability of low-cost resources. Multinational companies are focusing on expanding their presence in this region. These factors are expected to propel market growth in Latin America. Oral solid dosage forms are cost-effective and comparatively easy to manufacture than other dosage forms. They are most commonly used pharmaceuticals for treating various disease conditions in North America, which in turn is driving growth of the market in this region.

Growing effluent consumers in APEJ countries such as China, India and Korea are boosting growth of the oral solid dosage pharmaceutical formulation market in this region. Consumers here are adopting wealthy-life-fast-paced western lifestyle, leading them to suffer western lifestyle-related diseases including diabetes, cancer, and obesity. This compels them in seeking innovative drug treatments, which in turn is expected to fuel market growth in APEJ. However factors such as decreasing productivity of Asian manufacturers and containment issues, and low R&D expenditure coupled with challenges incurred in USFDA compliance are expected to impede growth of the market in APEJ.

Key players identified in FMI’s report include AstraZeneca Plc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., Boehringer Ingelheim GmbH, Hoffman-La-Roche Ltd., Johnson & Johnson, Biogen Inc., Bayer AG, Teva Pharmaceticals, Amgen Inc., Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co., Ltd., Shire Plc., Celgene Corporation, Astellas Pharma Inc.

Speak To Analyst about queries @ https://www.futuremarketinsights.com/ask-question/rep-gb-2782

Table of Content

1.Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2.Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3.Oral Solid Dosage Pharmaceuticals Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4.North America Oral Solid Dosage Pharmaceuticals Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Regional Market Dynamics

4.2.1.Drivers

4.2.2.Restraints

4.2.3.Trends

4.3. Historical Market Size (US$ Mn) By Country, 2012-2016

4.3.1.U.S.

4.3.2.Canada

4.4. Market Size (US$ Mn) Forecast By Country, 2017-2027

4.4.1.U.S.

4.4.2.Canada

4.5. Historical Market Size (US$ Mn) By Dosage Form, 2012-2016

4.5.1.Tablets

4.5.2.Capsules

4.5.3.Powders

4.5.4.Others

4.6. Market Size (US$ Mn) Forecast By Dosage Form Type, 2017-2027

4.6.1.Tablets

4.6.2.Capsules

4.6.3.Powders

4.6.4.Others

Plywood Market to Garner Brimming Revenues by 2028

Global infrastructural development has reached newer heights in the last few years, with massive constructions – both residential and commercial – mushrooming across both Tier 1 and Tier 2 cities across the world. This has led to impressive growth of the global building and construction industry and as a consequence positively impacted revenues of ancillary industries. Plywood is an inherent component of the construction industry – being widely used in manufacturing readymade and customized furniture.

Get Sample of the Report : https://www.futuremarketinsights.com/reports/sample/rep-gb-3463

“Growth in global consumption of plywood is pegged to increase at a decadal rate of 4.6% to reach 164,402 cubic meters by the end of 2022. This growth is attributable to the continuous demand from end-use industries especially the furniture production industry.” — Future Market Insights

Future Market Insights (FMI) throws light on some of the key factors boosting revenues in the global market for plywood. Plywood finds increasing use across diverse applications ranging from furniture, flooring, and packaging of high-value goods. This is anticipated to boost sales of plywood in the global market, according to Future Market Insights forecasts. A growth in residential and commercial spaces across the world has further boosted the demand for readymade and aesthetically designed furniture, incorporating extensive use of plywood. With people opting for designer furniture, the demand for plywood from the furniture industry is already peaking and this is anticipated to augment revenues in the global plywood market.

Besides, there is an increasing global phenomena promoting the use of wood and wood based products in the construction of both residential as well as commercial buildings. This trend is being supported by laws enforced at the administrative level. For instance, Japan’s “Act for Promotion of Use of Wood Products in Public Buildings, 2010” seeks to encourage the use of plywood in the construction sector. Global construction projects focusing on wooden skyscrapers such as the Oakwood Timber Tower are also expected to positively impact demand for plywood in the coming years.

Wood and wood based products such as plywood are eco-friendly in nature, encouraging the plantation of trees to meet the rising demand. Plywood and other ancillary wood products contribute to environmental protection. This is another factor acting in favour of the plywood market.

This study by FMI on the plywood market further identifies the growing importance of plywood in the global packaging industry as a key demand driver. “Plywood has enhanced mechanical strength besides being lightweight in nature. Plywood is also reusable and helps save on costs. This makes plywood the best packaging option for various types of products. With the current ban on plastic for product packaging, plywood is being increasingly adopted as a highly effective raw material to package different types of goods. This is expected to boost revenues in the global plywood market.”

Lucrative Opportunities Lie in the African Timberlands for both Existing Players and New Market Entrants

The presence of vast expanses of land in Africa coupled with the overall low costs of maintenance and production in the region make Africa a very attractive choice for the growth of forestry and the manufacturing of wood products, particularly plywood. Manufacturers in the global plywood market are looking at lucrative growth prospects in the African continent, given the region’s huge natural timberlands and mature plantations. Harvesting of plywood in the African forests is both cost-effective and environment friendly. This is boosting the setting up of backward integrated units manufacturing plywood, hence creating highly lucrative opportunities for players in the global plywood market.

Massive growth of the global construction industry has resulted in the pumping in of huge infrastructure investments by both private sector and public sector enterprises. This is likely to broaden the horizon for regional manufacturers of plywood with endless possibilities for revenue growth.

Ask For Regional Data : https://www.futuremarketinsights.com/ask-regional/rep-gb-3463

Adoption of Plywood in Digital Printing Trending the Global Market

Plywood is increasingly finding application as a substrate in high-scale inkjet printing projects. Plywood is used as an alternative to aluminium and plastic sheets owing to its non-reflective nature. Digitally printed plywood serves as an excellent substitute for several outdoor applications such as fence and road signs, as it is highly durable. This is the latest trend dotting the global plywood landscape, pushing revenues in the global market.

Policosanol Market Revenue Growth Predicted by 2031

The policosanol market is growing at a significant rate owing to increasing benefits derived from policosanol in the nutraceutical industry. According to a study by Future Market Insights (FMI), the overall valuation of the market is expected to surpass US$ 282 Mn in 2021. Growth will remain positive, especially as industries realize the clinical utilities of policosanols.

The presence of antioxidant properties in policosanol has resulted in its inclusion in the treatment of degenerative diseases like cardio-vascular disease and diabetes. Therefore, increasing health conscious among consumers is fuelling the demand for policosanol products.

Along with nutraceutical properties, policosanols have proven beneficial in acne treatments, skin repairing that makes it even more used ingredient worldwide. Several dermatologist and dieticians around the globe consider policosanol as a key compound, which is easily available in plants such as sugarcane, wheat, and rice. Policosanols are very useful for acne prone skin as these ensure that pores are clear of oil as it acts as an anti- seborrheic agent.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8934

Other skin benefits of using policosanol products are it reduces ageing process and helps in skin tightening. Escalating demand for policosanols in cosmetic and personal healthcare products is a major factor driving the policosanols market growth during the forecast period.

Consumer areeven suggested to make policosanol a part of their dietary intake. Policosanol at extraction stage is a potent source of active enzymes, minerals, vitamins, and proteins. Therefore, increasing health consciousness among consumers is fuelling the demand. According to the report, dietary supplements segment will emerge as a key application, accounting for over 30% of sales in the market in 2021.

Key Takeaways from Policosanols Market Study

  • Increasing focus on health and wellness will drive sales, enabling the policosanol market exhibit 5.9% CAGR between 2021 and 2031
  • The U.S holds over 80% share in the North America policosanol market, thanks to increasing use of policosanol as a key ingredient in pharmaceuticals and nutraceutical formulation
  • The U.K. will emerge as a chief market, exhibiting steady y-o-y growth at 2.2% in 2021
  • Increasing focus on health and wellness will drive sales in France and Germany
  • East Asia remains a chief market, driven by increasing demand from China and South Korea

“Diverse applications will continue supporting the expansion of policosanols market. Steered by ongoing trends, manufacturers are likely to focus on product launches to be able to offer products that suit consumer requirements,” said a lead analyst at FMI.

policosanol market region wise plc position and notable trends, 2021

Application in Cosmetic Industry Will Boost Growth

Consumers have become conscious about their skin and are looking for natural products especially for skincare and hair care. Cosmetics and skin care industry has seen tremendous surge in the use of policosanol moisturizer products as it provides various skin benefits such as tissue repair, elasticity, and depigmentation, thus making the skin look healthy and radiant.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8934

Use of Policosanol in Animal Feed is Fueling the Demand

Policosanols aremostly used in specialized feeding applications with monogastric animals, such as in milk replacers. The use of policosanol in pet foods as well as livestock feed has shown animprovement in the animals’ overall health. Manufacturers have great scope of business as in animal feed industry and animal feeders are demanding plant derived products as  more effective in terms of nutrition.

Who is winning?

Some of the key players operating in the Policosanols market areAmbePhytoextracts, Marcor- An Azelis Company, Douglas Laboratories, Now, Garuda International, Inc, Hainan Zhongxin Chemical, Hainan Zhongxin Chemical, Herblink Biotech Corporation, HuzhouShengmaBiochem Co. Ltd.Key players are adopting strategies like new product development, acquisition, sustainable partnership with distributors etc. for policosanols market.

  • In 2019, Garuda International, Inccompanyhas launched upgraded version of LesstanoL® Sugar Cane Wax Policosanol / Octacosanol. It is a ingredient which can used in many types of formulation of dietary supplement tablets or capsules.
  • In 2019 ZOI Research, The company launched its Certified-Organic version  ZOI Research, Cholesterol Support, 90 Vegetarian Capsules. To ensure lipid metabolism for cholesterol level management.
  • In 2020 India Glycols Ltd., The company launches various Phytochemicals / nutraceuticals as Ennature Biopharma is in the business of manufacturing natural active pharmaceutical ingredients (APIs), standardized botanical extracts and spice extracts for the beverage, dietary supplement, functional food, pharmaceutical and cosmeceutical industries.
  • In 2019 Mediplus, The company launched policosanols tablets . It is a packet of 60 tablets that is formulated using advance techniques in New Zealand. It not only support healthy cholesterol levels but also enhances stamina.
  • In 2020 Cyvex Nutrition, Inc., The company launched new tablets called as Swanson Ultra Policosanols supplements. These supplements are among the best sellers in 2020. It helps in maintaining a good cardiovascular health. As policosanols help in combating health issues.

Get Valuable Insights into Policosanols Market

Future Market Insights, in its new report, presents an unbiased analysis of the policosanols market, covering historical demand data 2016-2020 and forecast figures for the period between 2021 and 2031. The study divulges compelling insights into the growth witnessed in the market. Based on the policosanols Market based on product type, has been classified into policosanols. The policosanolis classified on the basis of source, grade, application and extraction process. Regionally, the policosanols market covers North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA.

Key Questions Answered in the Report

Which is the most lucrative market for policosanol?

Which is widely used source of policosanol?

Who is the leading end user of policosanol?

Which are some of the leading companies offering policosanol?

Which is the most preferred process for extracting Policosanol?

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/8934

Contact Us:

Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Mass Finishing Consumables Market Indicates Notable CAGR growth by 2029| Business Strategy & Forecast

[288 Pages Report]  According to Future Market Insights (FMI), the global mass finishing consumables market registered a year-on-year (YoY) growth of 4.7% in 2021. Demand in the mass finishing consumables market is projected to grow at a value of 4.9% CAGR between 2022 and 2029. Future Market Insights (FMI) forecasts the market value to top US$ 206.8 Mn in 2022.

Sales of mass finishing consumables are primarily driven by the increasing demand for surface finishing from various end-use industries such as automotive, aerospace, and general and industrial engineering. As indicated in a new Future Market Insights (FMI) study, the global mass finishing consumables market is estimated to be valued at over US$180 Million by the end of 2019, demonstrating moderate growth at a less than 5% CAGR during the forecast period, 2019 – 2029.

Key Takeaways – Global Mass Finishing Consumables Market

  • Non-metallic abrasives provide more contact area during finishing process than metallic ones, thus enabling the dimensions of parts to stay intact. Furthermore, non-metallic abrasives are best suited for both wet and dry applications. This leads to growing preference for non-metallic abrasives (ceramic, plastic, and porcelain) over metallic abrasives (such as steel).
  • Ceramic and plastic mass finishing consumables are estimated to account for more than 70% of total mass finishing consumables worldwide.
  • Plastic mass finishing consumables are generally recommended for use with softer metals, such as aluminum, brass, and zinc.
  • Use of fixtures is an upcoming trend. This process increases flow of media onto component surface, thereby contributing to an increased finishing action.

Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10691

New entrants in the global mass finishing consumables market can benefit by penetrating emerging economies in East Asia, where substantial growth is seen in the manufacturing sector.

Implementation of digitization and automation technologies over conventional technologies in the production line, product innovation, and footprint expansion remain key strategies followed by mass finishing consumables manufacturers to enhance productivity and to capture new market opportunities.

Reducing Third-party Dependence for Finishing Services to Propel Market Growth

Sustainable growth of investment in the manufacturing sector is expected to play a key role in driving the growth of the mass finishing consumables market across the globe. From the perspective of end-use industries, surface finishing is used in almost in every industry for cleaning and refurbishing metallic and non-metallic parts. End users are dependent on third-party service providers, which increases production cost and negatively impacts profitable margins.  The high cost involved influences such end users to opt for in-house surface and finishing technologies and to enhance productivity along with reducing cost and time.

Buy this report @ https://www.futuremarketinsights.com/checkout/10691

Interested in More Information?

A new market report on mass finishing consumables published by Future Market Insights brings to the fore a pin-point analysis of the market, and offers comprehensive information with historical demand data for 2014 – 2018 and forecast statistics for 2019 – 2029. The study offers insightful information on the global mass finishing consumables market based on various categories – media type (ceramic, plastic, steel, aluminium oxide, and others), application (deburring, pressure deburring, grinding, polishing, and ball furnishing, among others), and end-use industry (automotive, aerospace, machine tooling, general manufacturing, construction, healthcare, and jewellery & accessories), across seven regions.